A retrospective study to assess effect of bendamustine and rituximab as a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia
Latest Information Update: 06 Apr 2021
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 06 Apr 2021 New trial record